丽珠医药集团股份有限公司丽 珠 Ｂ2004年年度报告（英文版）

1 Livzon Pharmaceutical Group Inc. Abstract of 2004 Interim Report §1 IMPORTANT NOTICE 1.1 The board of directors ("the Board") of Livzon Pharmaceuti

1 LIVZON PHARMACEUTICAL GROUP INC. FIRST QUARTERLY REPORT FOR 2004 (a joint stock limited company incorporated in the People’s Republic of China with

1 LIVZON PHARMACEUTICAL GROUP INC. 2003 ANNUAL REPORT I. IMPORTANT NOTICE Important Notice: The board of directors of the Livzon Pharmaceutical Group

1 LIVZON PHARMACEUTICAL GROUP INC. 2002 ANNUAL REPORT I. IMPORTANT NOTES The Board of Directors of Livzon Pharmaceutical Group Inc. (hereinafter refe

Chapter 1 Important Notice and Table of Contents Important Notice: the Board of directors of our company guarantee that there is no false record, mis

Stock Code: 000513, 200513 Stock Name: S Livzon, Livzon-B Announcement No.: 2006-29 LIVZON PHARMACEUTICAL GROUP INC. 2006 THIRD QUARTERLY REPORT 1. I

丽珠医药集团股份有限公司2005年第三季度报告 1 Stock Code: 000513, 200513 Stock Name: Livzon Group, Livzon-B Announcement No.: 2005-25 LIVZON PHARMACEUTICAL GROUP INC. 20

1 Stock code: 000513, 200513 Short form of stock: Livzon Group, Livzon B No.: 2005-10 LIVZON PHARMACEUTICAL GROUP INC. 2005 FIRST QUARTERLY REPORT 1.

1 LIVZON PHARMACEUTICAL GROUP INC. Third Quarterly Report for 2003 1. Important Notice 1.1 The board of directors of the Company confirms that there

LIVZON PHARMACEUTICAL GROUP INC. SEMI-ANNUAL REPORT 2002 (SUMMARY) I. IMPORTANT NOTE The Board of Directors of Livzon Pharmaceutical Group Inc. (here